Raising a modern pharma CDMO

Four young companies built with intention tackle the future of medicine

Be Sure To Read

2024 pharma predictions: Therapeutic advances, manufacturing tech

In our two-part series, leaders weigh in on what the pharma industry can expect in the coming year
Pm2303 Hero 854x480 Cover Story
Pm2303 Hero 854x480 Cover Story
Pm2303 Hero 854x480 Cover Story
Pm2303 Hero 854x480 Cover Story
Pm2303 Hero 854x480 Cover Story

Nevertheless, they persisted

How drugmakers are fighting to keep reproductive health drugs available, safe and legal

Anticipating AI regulations in pharma manufacturing

In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation

FDA decisions to watch in 2024   

This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more

5 Pharma changemakers

The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry
microsoftteamsimage_9
microsoftteamsimage_9
microsoftteamsimage_9
microsoftteamsimage_9
microsoftteamsimage_9

2024 pharma predictions: Regulations, sustainability and culture

In part 2 of our series, leaders weigh in on what the pharma industry can expect in the coming year

Gilead buys early-stage IL-12 asset from Xilio 

In a deal that could reach $648 million, Gilead bets on a phase 1 tumor-activated IL-12 program

Akebia snags FDA approval for anemia drug, finally

Vadadustat initially faced rejection in 2022, followed by an additional CRL in 2023

Blackstone backs Moderna flu program with $750M investment

With Moderna about to file its seasonal flu vaccine with regulators, Blackstone backs its mRNA tech

Bayer to let go of 90 workers at NJ site

The news follows shortly after the drugmaker announced major layoffs at its German facility

Exclusives

Pharma events calendar

Keep track of in-person industry events.


Pharma Innovation Awards

Now accepting submissions for 2024!


Funny Pharm

Submit your caption to cartoons created by award-winning artist Jerry King.


Articles

The latest content from industry thought leaders.


Editors' (re)View

Weekly takes on things going on in the pharma world.

White paper: Stop sweating temperature excursions

Advanced chemical indicators give you the peace of mind that comes from reliable insights into your supply chains.

White paper: A path to 24/7 success for your company

Learn how digitalization can drive 24/7 success in your facility with our newest white paper.
life_sciences
life_sciences
life_sciences
life_sciences
life_sciences

White paper: System integration in liquid handling

Considerations for obtaining optimal results in laboratory and medical devices

White paper: Adopting novel technologies to improve mAb processes

Are purification strategies for mAbs moving you forward, or holding you back?

White paper: Approaches to alleviating subcutaneous pain at injection sites

High concentration mAbs can create challenges for subcutaneous injection, namely pain at the injection site. This peer-reviewed article compares buffer formulation options, and...

White paper: Enhancing virus clearance process capability using a biodegradable detergent

Effective viral clearance is at hand with the new, biodegradable J.T.Baker® Viral Inactivation Solution. A sustainable alternative to Triton X-100, this cGMP-ready solution supports...

5 considerations for successful CGT fill-finish scale up

What should you prioritize to successfully scale cell and gene therapy fill-finish processes? And how can you minimize manual involvement, reduce training requirements, and deliver...

Excipient-based strategies to harness complex therapeutics

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.

Bringing down the barriers to process monitoring in biopharma

How modern process analytical technologies such as Raman spectroscopy can improve quality control
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am

Bridging the gap between R&D and GMP

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
Pm Article Option 4
Pm Article Option 4
Pm Article Option 4
Pm Article Option 4
Pm Article Option 4

7 challenges of NGS-based biomarkers

Next generation sequencing has unprecedented power in biology, but has yet to reach its full potential in medicine

AAM
Generic

Charting a sustainable path for generics

Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting
Contract Manufacturing

INCOG Biopharma: Pedaling towards excellence

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology
Contract Manufacturing

Cellares: A disruptive impact on cell therapy

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

Slideshows

Quality & Risk

[Slideshow] 5 steps to improve your contamination control strategy

A robust contamination control strategy isn't merely a guideline, it's a necessity
Microsoft Teams Image (7)
Microsoft Teams Image (7)
Microsoft Teams Image (7)
Microsoft Teams Image (7)
Microsoft Teams Image (7)
Home

[Slideshow] Pharma Manufacturing's essential reference guide

Quick answers to all your pharma manufacturing questions
Shutterstock 749369605
Shutterstock 749369605
Shutterstock 749369605
Shutterstock 749369605
Shutterstock 749369605
Home

[Slideshow] What keeps pharma up at night?

13 pharma scaries….and solutions that offer reprieve